Aurinia Pharmaceuticals Cash Conversion Cycle 2011-2025 | AUPH

Annual Cash Conversion Cycle Aurinia Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
633	888	1.24 K	4.54 K	3.71	394	145	54.1	110	25.6	65.3	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.54 K	3.71	736

Quarterly Cash Conversion Cycle Aurinia Pharmaceuticals

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
523	545	-	497	374	457	-	401	1.69 K	5.43 K	-	506	689	6.93 K	49.2	5.59 K	4.27 K	23.9 K	-	-	-	560	579	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
23.9 K	49.2	3.12 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.79	2.35 %	$ 795 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.04	4.83 %	$ 235 M	USA
Aptevo Therapeutics APVO	-47.4	$ 0.93	-8.81 %	$ 257 K	USA
Catalyst Biosciences CBIO	391	$ 12.37	2.06 %	$ 814 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 26.83	0.94 %	$ 1.73 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 83.59	1.95 %	$ 8.63 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.45	0.91 %	$ 2.9 B	USA
CorMedix CRMD	-215 K	$ 12.19	1.75 %	$ 621 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.81	1.36 %	$ 1.3 B	USA
Anika Therapeutics ANIK	270	$ 9.48	0.96 %	$ 139 M	USA
Eton Pharmaceuticals ETON	-6.66	$ 16.99	2.66 %	$ 436 M	USA
Exelixis EXEL	5.31	$ 46.51	-0.21 %	$ 13.5 B	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 591.15	0.02 %	$ 44.8 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.53	-0.39 %	$ 15.9 M	USA
AstraZeneca PLC AZN	-58	$ 92.45	0.34 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 10.81	2.95 %	$ 699 M	USA
Biogen BIIB	387	$ 176.33	0.86 %	$ 25.7 B	USA